intervencioncoronariapercutaneavsbypassenenfermedadmultivasos
DESCRIPTION
Indicaciones y métodos de revascularizacion coronaria en pacientes con múltiples vasos,TRANSCRIPT
![Page 1: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/1.jpg)
![Page 2: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/2.jpg)
![Page 3: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/3.jpg)
![Page 4: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/4.jpg)
![Page 5: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/5.jpg)
![Page 6: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/6.jpg)
![Page 7: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/7.jpg)
• Significant coronary stenosis:– LMCA stenosis ≥50% luminal diameter narrowing in the
worst view by visual assessment– Epicardial non-LMCA stenosis ≥70% luminal diameter
narrowing in the worst view by visual assessment
• “Borderline” coronary stenosis:– Epicardial non-LMCA stenosis 50-60% luminal diameter
narrowing
Patel, et al. JACC 2012; 59:
![Page 8: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/8.jpg)
![Page 9: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/9.jpg)
![Page 10: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/10.jpg)
![Page 11: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/11.jpg)
masculino 51 AÑOSORIGEN UNICO DE AMBAS CORONARIAS
![Page 12: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/12.jpg)
![Page 13: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/13.jpg)
![Page 14: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/14.jpg)
![Page 15: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/15.jpg)
![Page 16: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/16.jpg)
![Page 17: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/17.jpg)
![Page 18: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/18.jpg)
![Page 19: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/19.jpg)
39 años, Masculino.Tabaco. IAM con elevación ST cara inferior
Archivos: Hospital Metropolitano Vivan Pellas
![Page 20: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/20.jpg)
Archivos: Hospital Metropolitano Vivan Pellas
STENT ENDEAVOR RESOLUTE3.5/30 mm
![Page 21: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/21.jpg)
From: WSJ July 6, 2011
Uncertainty about “Uncertain”
![Page 22: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/22.jpg)
![Page 23: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/23.jpg)
![Page 24: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/24.jpg)
![Page 25: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/25.jpg)
![Page 26: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/26.jpg)
![Page 27: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/27.jpg)
![Page 28: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/28.jpg)
The Synergy between Percutaneous Coronary
Intervention with TAXUS and Cardiac Surgery:
The SYNTAX Study
Primary Endpoint Results at One Year in the Randomized Cohort
Patrick W. Serruys MD PhDFriedrich W. Mohr MD PhD
On behalf of the SYNTAX investigators
Conflicts of Interest: None
![Page 29: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/29.jpg)
Patient ProfilingLocal Heart team (surgeon & interventional cardiologist) assessed each patient in regards to :
• Patient’s operative risk (EuroSCORE & Parsonnet score)
• Coronary lesion complexity (Newly developed SYNTAX score)
• Goal: SYNTAX score to provide guidance on optimal revascularization strategies for patients with high risk lesions
Sianos et al, EuroIntervention 2005;1:219-227Valgimigli et al, Am J Cardiol 2007;99:1072-1081Serruys et al, EuroIntervention 2007;3:450-459
BARI classification of coronary segmentsLeaman score, Circ 1981;63:285-299Lesions classification ACC/AHA , Circ 2001;103:3019-3041Bifurcation classification, CCI 2000;49:274-283CTO classification, J Am Coll Cardiol 1997;30:649-656
No. &
Location
of lesion Left
Main
Tortuosity
3 VesselThrombus
BifurcationCTO
Calcification
SYNTAX
SCORE
Dominance
![Page 30: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/30.jpg)
![Page 31: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/31.jpg)
![Page 32: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/32.jpg)
Patient 1
Patient 1 Patient 2
Patient 2
SYNTAX SCORE 21 SYNTAX SCORE 52
LCx 70-90%
LAD 70-90%
RCA2 70-90%
RCA3 70-90%
LM 99%
LCx 100%
LAD 99%
RCA 100%
There is ‘3-vessel disease’ and ‘3-vessel disease’
![Page 33: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/33.jpg)
![Page 34: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/34.jpg)
![Page 35: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/35.jpg)
![Page 36: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/36.jpg)
![Page 37: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/37.jpg)
![Page 38: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/38.jpg)
![Page 39: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/39.jpg)
![Page 40: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/40.jpg)
![Page 41: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/41.jpg)
![Page 42: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/42.jpg)
![Page 43: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/43.jpg)
![Page 44: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/44.jpg)
![Page 45: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/45.jpg)
Appropriate Use Criteria for Coronary Revascularization Focused Update 2012
Endorsed by:
![Page 46: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/46.jpg)
Date of download: 9/24/2014
Copyright © The American College of Cardiology. All rights reserved.
From: ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography
J Am Coll Cardiol. 2012;59(9):857-881. doi:10.1016/j.jacc.2011.12.001
Method of Revascularization of Multivessel Coronary Artery Disease
A = appropriate; CABG = coronary artery bypass grafting; CAD = coronary artery disease; CTO = chronic total occlusion; I = inappropriate; LAD = left anterior descending artery; PCI = percutaneous coronary intervention; SYNTAX = Synergy Between PCI With TAXUS and Cardiac Surgery; U = uncertain.
Figure Legend:
![Page 47: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/47.jpg)
MasculinoDiabético72 años
![Page 48: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/48.jpg)
![Page 49: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/49.jpg)
![Page 50: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/50.jpg)
![Page 51: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/51.jpg)
![Page 52: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/52.jpg)
![Page 53: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/53.jpg)
![Page 54: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/54.jpg)
![Page 55: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/55.jpg)
![Page 56: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/56.jpg)
![Page 57: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/57.jpg)
![Page 58: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/58.jpg)
![Page 59: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/59.jpg)
![Page 60: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/60.jpg)
1. EN SINDROMES CORONARIOS AGUDOS LA INTERVENCION PERCUTANEA ES EL METODO DE REVASCULARIZACION DE ELECCION.
2. EL BY PASS DE URGENCIA ES UNA INDICACION LIMITADA Y MUY RARA EN CONTEXTO ACTUAL
3. LA INTERVENCION CORONARIA PERCUTANEA ES UNA ESTRATEGIA IDEAL PARA LA REVASCULARIZCION EN LA MAYOR PARTE DE LOS ESCENARIOS DEL PACIENTE ESTABLES. BY PASS ES MEJOR EN ANATOMIAS MAS COMPLEJAS.
4. LA ANGIOGRAFIA CORONARIA Y LA MEDICION DE FFR OFRECE UNA VALORACION MAS COMPLETA DE LA ISQUEMIA MIOCARDICA Y PERMITE RECLASIFICAR LOS PACIENTES PARA ADECUAR LA ESTRATEGIA DE REVASCULARZACION
![Page 61: Intervencioncoronariapercutaneavsbypassenenfermedadmultivasos](https://reader033.vdocument.in/reader033/viewer/2022060121/559430801a28ab2e3d8b4743/html5/thumbnails/61.jpg)